http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509881/
Abstract
Warfarin
is a commonly used anticoagulant that has been associated with several
significant cutaneous side effects, most notably warfarin-induced skin
necrosis. A lesser known adverse reaction to warfarin is
warfarin-induced venous limb gangrene. Both cutaneous adverse effects
share the same pathophysiology, but are clinically quite different. The
majority of cases of warfarin-induced venous limb gangrene has been in
patients with cancer or heparin-induced thrombocytopenia. However, other
hypercoagulable disease states, such as the antiphospholipid antibody
syndrome, can be associated with venous limb gangrene. In order to
increase recognition of this important condition, the authors report a
case of warfarin-induced venous limb gangrene in a patient with presumed
antiphospholipid antibody syndrome and review the literature on
warfarin-induced venous limb gangrene.
Warfarin
is a commonly used anticoagulant that has been associated with several
significant cutaneous side effects. The authors report a case of
warfarin-induced venous limb gangrene in a patient with presumed
antiphospholipid antibody syndrome (APS). Warfarin-induced venous limb
gangrene is a distinct entity from warfarin-induced skin necrosis. Due
to its infrequency and the fact that it presents much differently than
warfarin-induced skin necrosis, physicians may dismiss the fact that
warfarin is the cause of a patient’s necrosis. For this reason, it is
important to recognize this as a separate clinical disease from
warfarin-induced skin necrosis with similar underlying pathophysiology.
This report of warfarin-induced venous limb gangrene is intended to
increase the index of suspicion for this rare drug reaction whose
effective treatment requires early diagnosis.
CASE REPORT
A
45-year-old man with a history of deep vein thrombosis (DVT) and
pulmonary embolus (PE) presented to his local hospital with bilateral
foot pain. He was immediately transferred to the university hospital for
treatment of cyanotic toes concerning for bilateral critical limb
ischemia. The patient’s medical history included chronic obstructive
pulmonary disease, alcohol abuse, seizure disorder, atrial fibrillation,
and nonischemic cardiomyopathy. Notably, three months prior to
presentation, he had been hospitalized with a large DVT and PE. He had
an inferior vena cava filter placed and was prescribed warfarin therapy.
The patient’s other home medications included phenytoin, diltiazem, and
an albuterol inhaler.
On arrival to the hospital, the
patient was admitted to the medical intensive care unit due to altered
mental status and acute respiratory failure requiring intubation and
mechanical ventilation. The patient’s international normalized ratio
(INR) at admission was 14.1 (normal 0.8–1.2), PTT was 46 seconds (normal
24–34 seconds), and platelets were 74,000/µL (normal
150,000–450,000/µL). Warfarin was held and vitamin K and fresh frozen
plasma were administered. Vascular surgery personnel assessed the
patient on arrival and did not find any evidence for critical limb
ischemia. Easily palpable bilateral dorsalis pedis and posterior tibial
pulses were found on exam. Dermatology was then consulted for assessment
of the patient’s toes.
On dermatological exam, sharply
defined, confluent, noninflammatory irregular purpura were present
involving all 10 toes, bilateral distal dorsal feet, and bilateral
distal soles with several overlying large hemorrhagic bullae (Figures 1A–1C).
Additional tense intact hemorrhagic and nonhemorrhagic bullae on
nonerythematous base were noted on otherwise uninvolved more proximal
foot and ankle. There was no appreciable livedo reticularis. Palpable
pulses were noted in bilateral lower extremities. Hands were not
involved.
Nasty looking pictures at the link.
No comments:
Post a Comment